Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23187 | 23976771 | JPEN J Parenter Enteral Nutr | The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23191 | 23973932 | J Hepatol | Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A23192 | 23973920 | Gastroenterology | Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis. | 2013 | Details |
| A23195 | 23971751 | Expert Rev Clin Immunol | Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. | 2013 | Details |
| A23199 | 23966104 | Thromb Haemost | The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. | 2013 | Details |
| A23200 | 23965360 | Endocr J | Rosiglitazone attenuates casein-induced hepatic endoplasmic reticulum stress in Sprague-Dawley rats: a novel model of endoplasmic reticulum stress. | 2013 | Details |
| A23204 | 23961483 | Indian J Endocrinol Metab | Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease? | 2013 | Details |
| A23211 | 23958268 | Atherosclerosis | Independent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north India. | 2013 | Details |
| A23212 | 23958203 | J Pharm Pharm Sci | Light-to-moderate ethanol feeding augments AMPK-α phosphorylation and attenuates SREBP-1 expression in the liver of rats. | 2013 | Details |
| A23214 | 23954219 | Gene | Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus. | 2013 | Details |
| A23215 | 23951308 | PLoS One | The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism. | 2013 | Details |
| A23218 | 23948064 | Biochem Pharmacol | Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A. | 2013 | Details |
| A23220 | 23945039 | Eur J Prev Cardiol | Gamma-glutamyltransferase, insulin resistance and cardiometabolic risk profile in a middle-aged African population. | 2013 | Details |
| A23225 | 23940240 | Pediatrics | Ethnic differences in the link between insulin resistance and elevated ALT. | 2013 | Details |
| A23228 | 23939604 | Am Fam Physician | Nonalcoholic fatty liver disease: diagnosis and management. | 2013 | Details |
| A23230 | 23935829 | PLoS One | Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. | 2013 | Details |
| A23235 | 23933938 | Hepatogastroenterology | Long-term (>=2 yr) efficacy of vitamin E for non-alcoholic steatohepatitis. | 2013 | Details |
| A23241 | 23930163 | Int J Prev Med | Effect of a Probiotic and Metformin on Liver Aminotransferases in Non-alcoholic Steatohepatitis: A Double Blind Randomized Clinical Trial. | 2013 | Details |
| A23242 | 23930133 | Hepat Mon | The effect of pioglitazone and metformin on liver function tests, insulin resistance, and liver fat content in nonalcoholic Fatty liver disease: a randomized double blinded clinical trial. | 2013 | Details |
| A23244 | 23929732 | Hepatology | Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. | 2014 | Details |
| A23247 | 23928404 | J Hepatol | Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity. | 2013 | Details |
| A23248 | 23928114 | J Appl Physiol (1985) | Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease. | 2013 | Details |
| A23249 | 23928105 | Metabolism | Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. | 2013 | Details |
| A23251 | 23924883 | Int J Environ Res Public Health | Relationship between retinal vascular caliber and coronary artery disease in patients with non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23254 | 23923370 | Trop Gastroenterol | Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A23262 | 23920034 | Clin Gastroenterol Hepatol | Endoscopic duodenal-jejunal bypass liner rapidly improves plasma parameters of nonalcoholic fatty liver disease. | 2013 | Details |
| A23263 | 23919592 | BMC Pediatr | Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth. | 2013 | Details |
| A23264 | 23917437 | Nutr Clin Pract | Pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A23267 | 23915028 | Free Radic Res | Mitochondrial dysfunction in non-alcoholic fatty liver disease and insulin resistance: cause or consequence? | 2013 | Details |
| A23269 | 23913732 | Obesity (Silver Spring) | Comparison of in vivo effects of insulin on SREBP-1c activation and INSIG-1/2 in rat liver and human and rat adipose tissue. | 2013 | Details |
| A23270 | 23913731 | Obesity (Silver Spring) | Adipocyte size is associated with NAFLD independent of obesity, fat distribution, and PNPLA3 genotype. | 2013 | Details |
| A23274 | 23909257 | Vnitr Lek | [Liver disorders in diabetic patients]. | 2013 | Details |
| A23275 | 23907039 | Int J Cardiol | RBBB is associated with an increased risk of NAFLD in young healthy individuals. | 2013 | Details |
| A23277 | 23905917 | J Allergy Clin Immunol | Innate sensors of pathogen and stress: linking inflammation to obesity. | 2013 | Details |
| A23281 | 23900008 | Food Chem Toxicol | The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease. | 2013 | Details |
| A23288 | 23896654 | Nutrients | Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease. | 2013 | Details |
| A23289 | 23896376 | Biochimie | Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function. | 2013 | Details |
| A23302 | 23884827 | Eur Rev Med Pharmacol Sci | Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus. | 2013 | Details |
| A23305 | 23880135 | Curr Opin Microbiol | Colonic bacterial metabolites and human health. | 2013 | Details |
| A23306 | 23879722 | Curr Med Res Opin | Effect of tobacco smoking and smoking cessation on plasma lipoproteins and associated major cardiovascular risk factors: a narrative review. | 2013 | Details |
| A23308 | 23876851 | Semin Cancer Biol | Obesity, insulin resistance, NASH and hepatocellular carcinoma. | 2013 | Details |
| A23311 | 23855304 | J Gastroenterol Hepatol | Family with sequence similarity 3 gene family and nonalcoholic fatty liver disease. | 2013 | Details |
| A23313 | 23855299 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. | 2013 | Details |
| A23321 | 23872500 | Gastroenterology | No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men. | 2013 | Details |
| A23324 | 23870449 | BMC Pediatr | Pediatric non alcoholic fatty liver disease: more on novel treatment targets. | 2013 | Details |
| A23326 | 23869143 | J Hum Reprod Sci | Prevalence of hepatic steatosis in women with polycystic ovary syndrome. | 2013 | Details |
| A23332 | 23865141 | J Pak Med Assoc | Are we ready for a new epidemic of under recognized liver disease in South Asia especially in Pakistan? Non alcoholic fatty liver disease. | 2013 | Details |
| A23333 | 23864802 | Korean J Intern Med | Effects of D-002, a mixture of high molecular weight beeswax alcohols, on patients with nonalcoholic fatty liver disease. | 2013 | Details |
| A23335 | 23861927 | PLoS One | Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet. | 2013 | Details |
| A23337 | 23861375 | Endocrinology | High-fat intake during pregnancy and lactation exacerbates high-fat diet-induced complications in male offspring in mice. | 2013 | Details |
| A23340 | 23860122 | Am J Physiol Endocrinol Metab | MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet. | 2013 | Details |
| A23342 | 23858556 | Hepatogastroenterology | Blood urea nitrogen is elevated in patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A23345 | 23855267 | Appl Physiol Nutr Metab | Role of physical activity in the treatment of nonalcoholic fatty liver disease in children and adolescents. | 2013 | Details |
| A23348 | 23851679 | Food Funct | Oat β-glucan inhibits lipopolysaccharide-induced nonalcoholic steatohepatitis in mice. | 2013 | Details |
| A23356 | 23845075 | Curr Diabetes Rev | The influence of diabetes in the pathogenesis and the clinical course of hepatocellular carcinoma: recent findings and new perspectives. | 2013 | Details |
| A23362 | 23843206 | Hepatology | Left ventricular dysfunction in obese children and adolescents with nonalcoholic fatty liver disease. | 2013 | Details |
| A23369 | 23837138 | Clin Mol Hepatol | The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults. | 2013 | Details |
| A23372 | 23837080 | Australas Med J | Primary non-alcoholic fatty liver disease in hypertensive patients. | 2013 | Details |
| A23378 | 23833274 | J Endocrinol | Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. | 2013 | Details |
| A23385 | 23828743 | Saudi J Gastroenterol | The role of endocannabinoids system in fatty liver disease and therapeutic potentials. | 2014 | Details |
| A23386 | 23827477 | Trends Endocrinol Metab | Non-alcoholic steatohepatitis: a microbiota-driven disease. | 2013 | Details |
| A23387 | 23826984 | Clin Sci (Lond) | Endothelial dysfunction in hyperandrogenic polycystic ovary syndrome is not explained by either obesity or ectopic fat deposition. | 2014 | Details |
| A23389 | 23826075 | PLoS One | Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in mice. | 2013 | Details |
| A23392 | 23820633 | Diabetologia | Fatty acids differentially regulate insulin resistance through endoplasm reticulum stress-mediated induction of tribbles homologue 3: a potential link between dietary fat composition and the pathophysiological outcomes of obesity. | 2013 | Details |
| A23396 | 23816341 | Diabetol Metab Syndr | Pleiotropic effects of rosuvastatin on the glucose metabolism and the subcutaneous and visceral adipose tissue behavior in C57Bl/6 mice. | 2013 | Details |
| A23399 | 23814606 | Therap Adv Gastroenterol | Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trial. | 2013 | Details |
| A23410 | 23805238 | PLoS One | High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats. | 2013 | Details |
| A23417 | 23801829 | World J Gastroenterol | What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? | 2013 | Details |
| A23418 | 23800945 | J Gastroenterol | Bofutsushosan, a Japanese herbal (Kampo) medicine, attenuates progression of nonalcoholic steatohepatitis in mice. | 2013 | Details |
| A23423 | 23796801 | Gene | Associations of the PTEN -9C>G polymorphism with insulin sensitivity and central obesity in Chinese. | 2013 | Details |
| A23430 | 23792151 | Biochimie | Zonation of glucose and fatty acid metabolism in the liver: mechanism and metabolic consequences. | 2013 | Details |
| A23433 | 23790128 | J Hum Nutr Diet | Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods. | 2013 | Details |
| A23440 | 23782071 | J Paediatr Child Health | Assessment of atherosclerosis in obese adolescents: positive correlation of mean platelet volume and carotid intima media thickness. | 2013 | Details |
| A23449 | 23770462 | Mol Cell Endocrinol | Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. | 2013 | Details |
| A23451 | 23770180 | J Am Coll Cardiol | Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. | 2013 | Details |
| A23459 | 23760677 | Diabetologia | A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid. | 2013 | Details |
| A23463 | 23758436 | Clin Sci (Lond) | Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice. | 2013 | Details |
| A23467 | 23754536 | Mol Med Rep | Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation. | 2013 | Details |
| A23470 | 23751754 | J Hepatol | From NAFLD in clinical practice to answers from guidelines. | 2013 | Details |
| A23474 | 23747246 | Cell Metab | Innate immune receptors: key regulators of metabolic disease progression. | 2013 | Details |
| A23475 | 23746214 | Clin Endocrinol (Oxf) | A comparison of cardiovascular risk indices in patients with polycystic ovary syndrome with and without coexisting nonalcoholic fatty liver disease. | 2013 | Details |
| A23476 | 23745619 | Metab Syndr Relat Disord | Nonalcoholic fatty liver disease and reduced serum vitamin D(3) levels. | 2013 | Details |
| A23479 | 23744740 | Am J Physiol Gastrointest Liver Physiol | CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism. | 2013 | Details |
| A23481 | 23742138 | J Agric Food Chem | Altered hepatic gene expression profiles associated with improved fatty liver, insulin resistance, and intestinal permeability after hydroxypropyl methylcellulose (HPMC) supplementation in diet-induced obese mice. | 2013 | Details |
| A23482 | 23740679 | J Pediatr Endocrinol Metab | Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents. | 2013 | Details |
| A23484 | 23739675 | Int J Mol Sci | In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
| A23490 | 23734760 | Metab Syndr Relat Disord | Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease. | 2013 | Details |
| A23496 | 23727264 | Gastroenterology | Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2013 | Details |
| A23500 | 23721173 | J Transl Med | Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS). | 2013 | Details |
| A23504 | 26201791 | Hepatol Int | Insulin resistance, inflammation, and nonalcoholic fatty liver disease in non-obese adults without metabolic syndrome components. | 2012 | Details |
| A23505 | 26201789 | Hepatol Int | Impact of combined therapy with alpha-lipoic and ursodeoxycolic acid on nonalcoholic fatty liver disease: double-blind, randomized clinical trial of efficacy and safety. | 2012 | Details |
| A23508 | 26201775 | Hepatol Int | Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival? | 2012 | Details |
| A23511 | 25755484 | J Clin Exp Hepatol | The future liver of the Asia pacific: fatter and firmer from more fructose and fortune? | 2012 | Details |
| A23516 | 23717739 | World J Hepatol | Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh. | 2013 | Details |
| A23519 | 23715726 | Am J Physiol Endocrinol Metab | Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet. | 2013 | Details |
| A23522 | 23711137 | Am J Chin Med | Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats. | 2013 | Details |
| A23529 | 23703888 | Am J Epidemiol | Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. | 2013 | Details |
| A23535 | 23702383 | Metabolism | Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway. | 2013 | Details |
| A23536 | 23702094 | BMC Pediatr | Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial. | 2013 | Details |
| A23542 | 23696823 | PLoS One | Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: new insight into the probiotics for the gut-liver axis. | 2013 | Details |